These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 577206)

  • 21. Ten years' experience with four cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, procarbazine (BEACOPP)-escalated followed by four cycles of baseline-dose BEACOPP in patients with advanced stage Hodgkin lymphoma: a single-center, retrospective study.
    Belada D; Štěpánková P; Sýkorová A; Žák P; Smolej L
    Leuk Lymphoma; 2015 Jul; 56(7):2013-8. PubMed ID: 25330440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy.
    Blumenfeld Z; Avivi I; Linn S; Epelbaum R; Ben-Shahar M; Haim N
    Hum Reprod; 1996 Aug; 11(8):1620-6. PubMed ID: 8921104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809.
    Fisher RI; Dana BW; LeBlanc M; Kjeldsberg C; Forman JD; Unger JM; Balcerzak SP; Gaynor ER; Roy V; Miller T
    J Clin Oncol; 2000 May; 18(10):2010-6. PubMed ID: 10811664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination therapy with cyclophosphamide, vincristine, procarbazine and prednisone in Hodgkin's disease and reticulum cell sarcoma.
    Isola LM; Cremerius de Sica SM; Palau M; Pereyra MA; Alzugaray AE
    Medicina (B Aires); 1971; 31(2):93-7. PubMed ID: 4935790
    [No Abstract]   [Full Text] [Related]  

  • 25. Updated Hodgkin's disease. C. Advanced disease and special problems. Combined chemotherapy-radiotherapy program.
    Fuller LM; Gamble JF
    JAMA; 1973 Jan; 223(2):168-9. PubMed ID: 4739457
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of cytostatic treatment on the coagulation system and fibrinolysis in patients with non-Hodgkin's lymphomas and acute leukemias.
    Zurborn KH; Gram J; Glander K; Delbrück K; Pelzer H; Löffler H; Bruhn HD
    Eur J Haematol; 1991 Jul; 47(1):55-9. PubMed ID: 1714407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of red cell aplasia and marrow fibrosis in non-Hodgkin's lymphoma.
    Kueh YK; Tan YO; Sng I; Rauff A
    Ann Acad Med Singap; 1983 Jul; 12(3):472-3. PubMed ID: 6689579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total body irradiation and cyclophosphamide, vincristine, prednisone in the treatment of favorable prognosis non-Hodgkin's lymphomas.
    Leimert JT; Corder MP; Tewfik HH; Guthrie R; Maguire LC; Gingrich RD
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1479-83. PubMed ID: 583417
    [No Abstract]   [Full Text] [Related]  

  • 29. Homonymous hemianopsia in a patient with Hodgkin's lymphoma in remission after BEACOPP chemotherapy.
    Bruessow C; Karrer U; Gubler J; Pless M
    J Clin Oncol; 2012 Apr; 30(12):e130-2. PubMed ID: 22393099
    [No Abstract]   [Full Text] [Related]  

  • 30. [A three-year experience with use of mabthera (rituximab) in treatment of indolent non-Hodgkin's disease refractory to standard chemotherapy].
    Korolenko VO; Gershanovich ML; Tikhonova VV
    Vopr Onkol; 2004; 50(4):421-5. PubMed ID: 15605764
    [No Abstract]   [Full Text] [Related]  

  • 31. Combination chemotherapy for advanced Hodgkin's disease in relapse following extensive radiotherapy.
    Cannellos GP; Young RC; DeVita VT
    Clin Pharmacol Ther; 1972; 13(5):750-4. PubMed ID: 5053816
    [No Abstract]   [Full Text] [Related]  

  • 32. Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination.
    Young RC; Johnson RE; Canellos GP; Chabner BA; Brereton HD; Berard CW; DeVita VT
    Cancer Treat Rep; 1977 Sep; 61(6):1153-9. PubMed ID: 332349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy of advanced lymphocytic lymphoma a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy.
    Canellos GP; DeVita VT; Young RC; Chabner BA; Schein PS; Johnson RE
    Br J Cancer Suppl; 1975 Mar; 2():474-80. PubMed ID: 1101933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-Hodgkin's lymphoma in Manitoba, 1968-77: the impact of chemotherapy.
    Deonarine L; Weinerman BH; MacDougall BK; Kemel S
    Can Med Assoc J; 1982 Apr; 126(7):807-11. PubMed ID: 7042060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multiple drug therapy in Hodgkin's disease, lymphosarcoma and reticulosarcoma].
    Con I; Daiber A; Donoso A; Osorio G; Mora F
    Rev Med Chil; 1972 Apr; 100(4):408-13. PubMed ID: 4557485
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparison of cyclophosphamide, vincristine, and prednisone (COP) with nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) in the treatment of nodular, poorly differentiated, lymphocytic lymphoma.
    Benjamin RS; Wiernik PH; O'Connell MJ; Chang P; Sutherland JC
    Cancer; 1976 Nov; 38(5):1896-902. PubMed ID: 1036467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Results of chemotherapy with cyclophosphamide, vincristine, methotrexate and prednisone in recurring or disseminated non-Hodgkin lymphomas in the University of Kiel Radiology Clinic].
    Liffers R
    Onkologie; 1981 Jun; 4(3):156-61. PubMed ID: 7022291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination chemotherapy of advanced lymphomas.
    Kurnick JE; Robinson WA
    Arch Intern Med; 1972 Jun; 129(6):908-13. PubMed ID: 5067727
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparative study of two drug combination in non-Hodgkin's lymphoma (author's transl)].
    Somoza N; Morgenfeld MC; Magnasco J; Pavlovsky S; Cavagnaro FJ; Saslavsky J; de Maria H; Macchi A; Suárez A
    Sangre (Barc); 1978; 23(4):418-25. PubMed ID: 705564
    [No Abstract]   [Full Text] [Related]  

  • 40. High dose chemotherapy and autologous stem cell transplantation for poor risk and recurrent non-Hodgkin's lymphoma: a single-center experience of 50 patients.
    Shim BY; Lee MA; Byun JH; Roh SY; Song CW; Park JN; Lee JW; Min WS; Hong YS; Kim CC
    Korean J Intern Med; 2004 Jun; 19(2):114-20. PubMed ID: 15366643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.